News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines released in the past hour.
  • No fresh economic data or central bank commentary published this hour.
  • No notable geopolitical incidents or government announcements reported this hour.
  • No material corporate earnings, M&A, or corporate guidance disclosed this hour.
  • Commodity, FX, and bond markets showed no sudden shocks in the past hour.
  • Overall market tone remained unchanged due to lack of new developments.

Latest Articles

Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

Entera Bio Ltd., a clinical stage biopharmaceutical company developing oral peptide therapies, has appointed Dr. Riccardo Paolo Camisasca as Chief Medical Officer. Dr. Camisasca brings over 30 years of global pharmaceutical experience and will strengthen Entera's clinical and late-stage development capabilities as the company prepares to initiate P…

Rezolve Ai Proves at-Scale Intelligence at the 2026 Football World Cup: 103 Million App Opens, 5.8 Million Location Events and 16 Stadiums

Rezolve Ai Proves at-Scale Intelligence at the 2026 Football World Cup: 103 Million App Opens, 5.8 Million Location Events and 16 Stadiums

Rezolve Ai showcased its AI-driven commerce technology at the 2026 Football World Cup, successfully connecting over 103 million app opens with nearly 6 million geofence location events across 16 stadiums. This live deployment validated their ability to integrate digital attention with physical presence in real time, offering brands and venues actio…

Zscaler and Carahsoft Expand Partnership to Deliver Enterprise-Proven Zero Trust Security to SMB and Mid-Market Customers

Zscaler and Carahsoft Expand Partnership to Deliver Enterprise-Proven Zero Trust Security to SMB and Mid-Market Customers

Zscaler, a leading cybersecurity company, has expanded its partnership with Carahsoft Technology to scale delivery of its Zero Trust Exchange platform targeting the underserved U.S. small and mid-market business segments. The collaboration aims to offer simpler, cost-effective, and streamlined cloud-native security solutions through Carahsoft's ext…

Fluke Empowers Calibration Laboratories with CalStudio Conduit and Intelligent Workflow Automation

Fluke Empowers Calibration Laboratories with CalStudio Conduit and Intelligent Workflow Automation

Fluke Corporation has released a new version of its CalStudio calibration management software, introducing CalStudio Conduit—a no-code workflow automation platform—and other features like Tool Crib for managing shared tools and enhanced asset location tracking. These updates aim to help calibration laboratories improve efficiency, reduce manual tas…

Unusual Whales and Siebert Financial Announce Strategic Partnership to Launch New Series of ETFs

Unusual Whales and Siebert Financial Announce Strategic Partnership to Launch New Series of ETFs

Siebert Financial Corp. announced a strategic partnership with Unusual Whales to develop and launch new exchange-traded funds (ETFs) that leverage unique market intelligence such as political trading disclosures and unusual options activity. This collaboration combines Unusual Whales’ data access and community with Siebert’s financial expertise and…

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Elutia Inc. has finalized the sale of its SimpliDerm human acellular dermal matrix business for up to $11 million, including an $8 million upfront payment. The transaction strengthens Elutia’s balance sheet with non-dilutive capital and enables the company to focus on developing and commercializing NXT-41x, an antibiotic-eluting biomatrix targeting…

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

CareCloud, Inc. (Nasdaq: CCLD) has partnered with KabaFusion to co-develop LailaCare, a first-of-its-kind AI-powered integrated platform designed to streamline and modernize home infusion therapy workflows and specialty pharmacy services. The platform aims to unify referral intake, patient engagement, revenue cycle management, and operational effic…

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Humacyte, a US-based biotech company, announced the first commercial implantations of Symvess, their FDA-approved bioengineered human blood vessel, performed by Dr. Jeromy Brink in Arizona. Symvess provides an off-the-shelf vascular graft option for emergency limb salvage surgeries, reducing the need for vein harvesting. This milestone marks a sign…

Saratoga Investment Corp. Announces Offering of Notes and BBB Investment Grade Rating from Egan-Jones Ratings Company

Saratoga Investment Corp. Announces Offering of Notes and BBB Investment Grade Rating from Egan-Jones Ratings Company

Saratoga Investment Corp. announced a registered public offering of unsecured notes expected to trade on the NYSE under the symbol "SAX". The company received a BBB investment grade rating from Egan-Jones Ratings Company. Proceeds from the offering will be used to redeem existing notes and repay indebtedness, supporting the company’s financial flex…

Jefferson Capital Announces Proposed Private Offering of Senior Notes

Jefferson Capital Announces Proposed Private Offering of Senior Notes

Jefferson Capital, Inc. announced a proposed private offering of $100 million senior notes due 2030 through its subsidiary Jefferson Capital Holdings, LLC. The proceeds are intended primarily to repay borrowings under its revolving credit facility and for general corporate use. The notes are offered to qualified institutional buyers and non-U.S. pe…

A 23-Hour Market, and the Rulebook That May Not Be Ready

A 23-Hour Market, and the Rulebook That May Not Be Ready

Nasdaq has proposed extending U.S. equities trading to almost 23 hours a day by adding an overnight session from 9 PM to 4 AM ET, with an 8 PM to 9 PM ET pause for processing and a targeted launch of December 6, 2026, subject to SEC approval. The exchange would limit overnight activity to limit orders, use static price bands, and require new connec…

Klarna Shares Plunge After Q2 Results Confirm Profit Slowdown

Klarna Shares Plunge After Q2 Results Confirm Profit Slowdown

Klarna's stock plunged 17.1% in pre-market trading after the company published its second-quarter 2026 results ahead of the open. Management's guidance pointed to a sequential revenue decline versus Q1 and a narrower adjusted operating profit range, while provisions tied to its longer-duration Fair Financing product continued to climb, intensifying…

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

AVITA Medical announced positive results from its PermeaDerm-I clinical study demonstrating that PermeaDerm, a biosynthetic wound matrix, provides comparable clinical outcomes to cadaveric allograft for temporary wound coverage, while delivering a 70% reduction in product cost and a 96% reduction in preparation time. The randomized controlled trial…

Insider Buying and Analyst Move Lift H&M Shares Ahead of Q3 Results

Insider Buying and Analyst Move Lift H&M Shares Ahead of Q3 Results

H & M Hennes & Mauritz B shares climbed after Citi placed the stock on a positive catalyst watch and raised its price target, while the Persson family disclosed a multi-million share purchase. The gains appear driven by these company-specific developments rather than a broader market rally ahead of the retailer’s third-quarter results next month.